European Dry Powdered Inhaler Market Trends, Growth, Future Analysis and Forecast 2019-2025

The European Dry Powdered Inhaler market was valued at around $3.7 billion in 2018 and is anticipated to grow at a substantial rate of 2.1% during the forecast period. Major countries that will contribute to the dry powdered inhaler market within the region includes UK, Germany, France, Italy, and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the dry powdered inhaler market.

Get Sample Copy of European Dry Powdered Inhaler Market at: https://www.omrglobal.com/request-sample/european-dry-powdered-inhaler-market

The major players of the European dry powdered inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and Bespak.

The European dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

For More Information get A full report of European Dry Powdered Inhaler is available at: https://www.omrglobal.com/industry-reports/european-dry-powdered-inhaler-market

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing dry powdered inhalers to cater to a wide range of customers within the region and across the globe. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

European Dry Powdered Inhaler Market Segmentation

European Dry Powdered Inhaler Market by Type

• Preventive Inhaler
• Reliever Inhaler
• Long Acting Bronchodilators Dry Powdered Inhaler

European Dry Powdered Inhaler Market by Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

European Dry Powdered Inhaler Market by End-User

• Homecare
• Hospitals and Clinics

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-dry-powdered-inhaler-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.